Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Potential Phytochemicals as Efficient Protease Inhibitors of 2019-nCoV

Version 1 : Received: 14 April 2020 / Approved: 15 April 2020 / Online: 15 April 2020 (10:00:52 CEST)



How to cite: Ranjan, A.; Chauhan, A.; Gurnani, M.; Jindal, T. Potential Phytochemicals as Efficient Protease Inhibitors of 2019-nCoV . Preprints 2020, 2020040240 (doi: 10.20944/preprints202004.0240.v1). Ranjan, A.; Chauhan, A.; Gurnani, M.; Jindal, T. Potential Phytochemicals as Efficient Protease Inhibitors of 2019-nCoV . Preprints 2020, 2020040240 (doi: 10.20944/preprints202004.0240.v1). Copy

Cite as: Ranjan, A.; Chauhan, A.; Gurnani, M.; Jindal, T. Potential Phytochemicals as Efficient Protease Inhibitors of 2019-nCoV . Preprints 2020, 2020040240 (doi: 10.20944/preprints202004.0240.v1). Ranjan, A.; Chauhan, A.; Gurnani, M.; Jindal, T. Potential Phytochemicals as Efficient Protease Inhibitors of 2019-nCoV . Preprints 2020, 2020040240 (doi: 10.20944/preprints202004.0240.v1). Copy CANCEL COPY CITATION DETAILS

Abstract

The novel coronavirus 2019 (nCov-2019/Covid-2019/2019-nCov) has become a pandemic in a very short span of time. It has caused significant loss to human lives, economy, daily life. The key development against the nCov-2019 remains apprehended when it comes to discovery of its vaccine or medicines for the treatment. Drugs used for the treatment of HIV ( inhibitors of HIV protease) are being largely used for the treatment of nCov-2019. Therefore, we conducted a study by docking a set of natural compounds with reported protease activity against HIV or SARS coronavirus against the protease of nCov-2019. The Bavachinin ranked the top among natural compounds with binding energy of -7.74±0.152 Kcal/mol, RMSD 0.823±0.024 Å, predicted pKd 5.59 and predicted dG of -7.56 Kcal/mol. The finding infers that these three compounds could have the potential to inhibit the nCov-2019 protease. The finding was supported with reputed research publications.

Subject Areas

COVID19 ; 2019-nCov, 3CLpro inhbitors

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.